Robert Nelsen - Insider Trading & Ownership

Location
8755 W. Higgins Road, Suite 1025, Chicago, IL
Summary
The estimated net worth of Robert Nelsen is at least $291M dollars as of August 5, 2025. Robert Nelsen is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $178M. Robert Nelsen is the Director, 10%+ Owner of Lyell Immunopharma, Inc. and owns shares of Lyell Immunopharma, Inc. (LYEL) stock worth about $83M. Robert Nelsen is the Director, 10%+ Owner of Prime Medicine, Inc. and owns shares of Prime Medicine, Inc. (PRME) stock worth about $23.5M. Robert Nelsen is the Director of Vir Biotechnology, Inc. and owns shares of Vir Biotechnology, Inc. (VIR) stock worth about $5.87M.
Signature
/s/ Ryan Brown, attorney-in-fact
All Insider Reports
All Insider Reports

Ownership of Robert Nelsen

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DNLI Denali Therapeutics Inc. Director $178M Jun 2, 2021
LYEL Lyell Immunopharma, Inc. Director, 10%+ Owner $83M Jun 14, 2024
PRME Prime Medicine, Inc. Director, 10%+ Owner $23.5M Aug 1, 2025
VIR Vir Biotechnology, Inc. Director $5.87M May 30, 2024
SANA Sana Biotechnology, Inc. Director, 10%+ Owner Jun 5, 2025

Insider Transactions Reported by Robert Nelsen:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.